Developing preference-based measures for diabetes: DHP-3D and DHP-5D

Slides:



Advertisements
Similar presentations
1 National Outcomes and Casemix Collection Training Workshop Strengths and Difficulties Questionnaire.
Advertisements

DEVELOPMENT OF A PREFERENCE-BASED, CONDITION SPECIFIC PATIENT REPORTED OUTCOME MEASURE FOR USE WITH VENOUS ULCERATION Simon Palfreyman 1, John E Brazier.
Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions A Case Study in Type.
There is a need to validate existing patient reported outcome measures (PROMS) to provide evidence on their validity. Subsequently, short measures can.
Utility Assessment HINF Medical Methodologies Session 4.
Valuing the SF-6D: a nonparametric approach using individual level preference data Part 1): The SF-6D and its valuation Samer A Kharroubi, Tony O’Hagan,
Modelling Cardinal Utilities from Ordinal Utility data: An exploratory analysis Peter Gilks, Chris McCabe, John Brazier, Aki Tsuchiya, Josh Solomon.
Utilising rank and DCE data to value health status on the ‘QALY’ scale using conventional and Bayesian methods John Brazier and Theresa Cain with Aki Tsuchiya.
MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH Brendan Mulhern 1, Keith Meadows 2, Donna.
Critical Appraisal of Clinical Practice Guidelines
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Dr Keith Meadows, DHP Research & Consultancy Ltd.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 11: Cost-utility analysis – Part 4.
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
1 The Patient Perspective: Satisfaction Survey Presented at: Disease Management Colloquium June 22, 2005 Shulamit Bernard, RN, PhD.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
Al wakeel J, Bayoumi M, Al Ghonaim M, Al Harbi A, Al Swaida A, Mashraqy A.
Decision Analysis Dr M G Dawes Centre for Evidence Based Medicine.
Evidence and Information for Policy Health as a multi-dimensional construct and cross-population comparability Colin Mathers (WHO) on behalf of Taskforce.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Evaluating Risk Adjustment Models Andy Bindman MD Department of Medicine, Epidemiology and Biostatistics.
Introduction ESTIMATING THE MINIMALLY IMPORTANT DIFFERENCE (MID) OF THE DIABETES HEALTH PROFILE (DHP-18) FOR TYPE 1 AND TYPE 2 DIABETES MELLITIS Brendan.
HERU is supported by the Chief Scientist Office of the Scottish Executive Health Department and the University of Aberdeen. The author accepts full responsibility.
Vicky Copley, PHE Risk Factor Intelligence
Can patients be satisfied to death? What was Joshua J. Fenton thinking? Ron D. Hays, Ph.D. July 21, 2015 UCLA Center for Maximizing Outcomes and Research.
DAWN2™ Study © 2013 Novo Nordisk A/S. All rights reserved DIABETES CARE – WHAT PATIENTS WANT Roz Rosenblatt London Regional Manager.
The measurement and comparison of health system responsiveness Nigel Rice, Silvana Robone, Peter C. Smith Centre for Health Economics, University of York.
Mental health workgroup UPDATE 15 TH WASHINGTON GROUP MEETING OCTOBER 2015.
Psychological sources of stress Daily Hassles. Psychological sources of stress: Daily Hassles & Uplifts There is a problem with Holmes & Rahe’s view that.
Instrument Development and Psychometric Evaluation: Scientific Standards May 2012 Dynamic Tools to Measure Health Outcomes from the Patient Perspective.
AN EXPLORATION OF PERSON- CENTRED CARE ACROSS ACUTE HOSPITAL SETTINGS IN IRELAND By Dr R Parlour & Dr P Slater.
ACNE CORE OUTCOMES RESEARCH NETWORK Information for new patient members 01/2016.
General Introduction Some Notes. Definition of Measurement “Measurement consists of rules for assigning numbers to observable attributes so as to represent.
Multivariate Analysis - Introduction. What is Multivariate Analysis? The expression multivariate analysis is used to describe analyses of data that have.
Using the BRFSS to Validate a New Measure of Participation
Intro to Qualitative Research Scientific Practice.
‘PhysioDirect’ for patients with MSK problems ECONOMIC MODEL OVERVIEW.
Professor Nancy J. Devlin Office of Health Economics Royal Statistical Society June 18 th 2015 Measuring and ‘valuing’ patient reported health.
Progress and future developments
Evaluating Patient-Reports about Health
Some epidemiological principles and methods
Professor David Parkin King’s College London
Sofija Zagarins1, PhD, Garry Welch1, PhD, Jane Garb2, MS
DATA COLLECTION METHODS IN NURSING RESEARCH
Professor Nancy Devlin Director of Research OHE
Running models and Communicating Statistics
CHAPTER 6, INDEXES, SCALES, AND TYPOLOGIES
WHO The World Health Survey General Introduction
Quality of Life Assessment
Evaluating Patient-Reports about Health
Development of an electronic personal assessment questionnaire to capture the impact of living with a vascular condition: ePAQ-VAS Patrick Phillips, Elizabeth.
+ THE DIABETES HEALTH PROFILE (DHP) DEVELOPMENT JOURNEY
The Centre for Community-Driven Research
Peer Support and Respite Improves Individual and Family Wellbeing in Young People Caring for an Adult with a Mental Health Problem Ailsa Grant, Rasa.
The valuation of disease-specific questionnaires for QALY analysis
First study published in JOGS.
Week 12 Slides.
Improving the performance reporting of primary care patient experience
Day 3 Psychosocial care, spirituality & bereavement
EAST GRADE course 2019 Introduction to Meta-Analysis
Our Commitments for Dementia in Sheffield: have your say
A Survey of Factors Influencing Holistic Management of Schizophrenia
BEC 30325: MANAGERIAL ECONOMICS
Measuring Palliative Care Outcomes
Multivariate Analysis - Introduction
Sabrina M. Figueiredo1,3, Alicia Rozensveig3, José A. Morais2, Nancy E
Measuring outcomes Emma Frew October 2012.
Proposal of a new scoring formula for the DLQI in psoriasis
Patient-reported Outcome Measures
Outcomes from social prescribing
Presentation transcript:

Developing preference-based measures for diabetes: DHP-3D and DHP-5D B Mulhern1,2, A Labeit1, D Rowen1, E Knowles1, K Meadows3, J Elliot4, J Brazier1 1. School of Health and Related Research, University of Sheffield, UK 2. University of Technology Sydney, Centre for Health Economics, Research and Evaluation, Sydney, Australia, UK 3. DHP Research and Consultancy, UK 4. Academic Unit of Diabetes, Endocrinology and Metabolism, University of Sheffield, UK

Why develop condition specific preference-based measures? Cost effectiveness arguments are increasingly important in influencing reimbursement decisions Generic measures (like EQ-5D) may not be valid or responsive for measuring the day to day impact of diabetes and its treatment Add value to existing condition specific PROMS to use them to estimate QALYs for economic evaluation

Diabetes Health Profile (DHP)-18 18 item condition specific questionnaire Three domains: Psychological distress (six items) Barriers to activity (seven items) Disinhibited eating (five items) Responses are on a four point likert scale e.g. never/sometimes/usually/always Low scores indicate high quality of life rescaled onto a 0-100 scale

Using the DHP-18 in economic evaluation The DHP in its current format cannot be used in economic evaluation using cost-per-QALY analysis as it does not incorporate preferences To incorporate preferences, there needs to be: Health state classification system Preference weights for each health state

Developing a preference-based condition specific measure from an existing instrument Extract a simplified health state classification from the instrument (often defines billions of possible ‘states’ or combinations) amenable to valuation Value a sample of states defined by the new classification using a technique like TTO Use multivariate statistical analysis to estimate an algorithm for scoring the new classification

Constructing the health state classification Aim is to construct a health state classification with minimum loss of information responses to the original instrument must be able to be unambiguously mapped onto it text of the items should be altered as little as possible Dataset used is cross sectional data set from 237 people with diabetes recruited at a hospital in S. Yorkshire Methodology outlined here is described fully in Brazier et al, 2012; Young et al, 2009) Dimensional structure Item selection

Dimensional structure Used factor analysis to identify structurally independent dimensions Results: The items were grouped into the 3 identified factors: Mood – 6 items from psychological distress items Eating – 5 items from disinhibited eating plus one barrier to activity Social limitations – 5 items from barriers to activity Expert input (clinician and nurse) suggested two extra dimensions: ‘hypoglycemic attacks’ and ‘vitality’

Item selection Informed by: Psychometric analysis: missing data, ceiling effects, floor effects Rasch analysis: item level ordering, differential item functioning, model fit, item range and spread across latent space All within the overall constraint of producing a classification that generates states amenable to valuation

Health state classification systems DHP-3D Mood: You never/sometimes/often/very often find yourself losing your temper over small things Social limitations: Your days are never/sometimes/usually/never tied to meal times Eating: When you start eating you find it very easy/quite easy/not very easy/not at all easy to stop DHP-5D Hypoglycemic attacks: You never/sometimes/usually/always worry about doing too much and going hypo Vitality: You are tired none/a little/some/most/all of the time

Valuation survey 300 interviews conducted with members of the UK general population: 150 for DHP-3D and 150 for DHP-5D There are 64 DHP-3D and 1280 DHP-5D health states in all – orthogonal array resulted in 65 states sampled in total Each respondent valued 9 health states using time-trade off (TTO) (in accordance with the NICE reference case) using LT-TTO for states worse than dead

Modelling the TTO data Data was analysed using a variety of models: OLS, RE GLS, Mean model Standard model defined as: Dependent variable, y, is TTO disvalue (1–TTO value) for health state i=1,2 …n valued by respondent j=1,2…m X is a vector of dummy explanatory variables for each level λ of dimension δ of the health state classification

DHP-3D decrements – REGLS SL2 0.022** SL3 0.044*** SL4 0.065*** Significant coefficients = 8 MAE = 0.117 MAE>0.05 = 66.5%

DHP-5D decrements – RE GLS consistent model Significant coefficients = 13 MAE = 0.119 MAE>0.05 = 72.8% M2 0.015 M3 0.027** M4 0.051*** E2 0.026** E3 0.043*** E4 0.043*** SL2 0.012 SL3 0.012 SL4 0.029*** H2 0.019* H3 0.035*** H4 0.065*** VT2 0.028*** VT3 0.044*** VT4 0.115*** VT5 0.173***

Observed vs. predicted values DHP-3D DHP-5D

Examples Utility value = 0.811 Utility value = 0.745 DHP-3D state 333 You often find yourself losing your temper over small things Your days are usually tied to meal times When you start eating you find it not very easy to stop DHP-5D state 34315 You often find yourself losing your temper over small things Your days are always tied to meal times When you start eating you find it not very easy to stop You never worry about doing too much and going hypo You are tired most of the time Utility value = 0.745

HASMID classification system Dimension Wording Health Mood Find yourself losing your temper over small things Hypoglycaemic attacks Worry about going hypo Vitality Tired Social limitations Days are tied to mealtimes Self management Control Feel you have control of your diabetes Hassle Find your life with diabetes is a hassle Stress Find your life with diabetes is stressful Support (All support you have; from family, friends and health care professionals) Feel supported with your diabetes Enhances dimensions of DHP-5D

CS PROMS converted to QALYs Preference-based measures PRO Population KHQ index KHQ Incontinence AQL-5D AQLQ Asthma OAB-5D Overactive Bladder Questionnaire Overactive Bladder EORTC-8D EORTC QLQ-C30 Cancer DEMQOL-5D and DEMQOL-P-4D DEMQOL/DEMQOL-proxy Dementia NEWQoL-6D NEWQoL Epilepsy VFQ-UI VFQ-25 Vision CORE-6D CORE-OM Psychological health ADQoL index ADQoL Atoptic dermatitis in Children SQoL-3D SQoL Sexual health CAMPHOR index CAMPHOR Pulmonary hypertension ReQoL (de novo) ReQoL Mental health

Discussion Demonstrated how PROMS can be converted into preference-based measures for calculating QALYs for use in economic evaluation Estimated relative importance of dimensions – e.g. vitality more important than worry about risk of hypos But: These values come from general population – patients might give different values DHP-3D and DHP-5D only go down to 0.717 and 0.618 respectively compared to minus 0.569 for EQ-5D-3L DHP does not measure the consequences of complications arising from diabetes – but the day to impact of the condition DHP does not cover the full impact of diabetes self-management on people’s lives – see the new HASMID measure (DHP-5D plus) Are different condition specific preference-based measures comparable for informing resource allocation?

References Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J. Measuring and valuing health for economic evaluation. Oxford: Oxford University Press 2007. Brazier J, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y. (2012) Developing and testing methods for deriving preference-based measures of health from condition specific measures (and other patient based measures of outcome). Health Technology Assessment, 2012;16(32) Brazier J, Tsuchiya A. Preference-based condition specific measures of health: what happens to cross programme comparability. Health Economics 2010, 19(2):125-129. Carlton J, Elliott J, Rowen D, Stevens K, Basarir H, Meadows K, Brazier J. Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voice. HEDS discussion paper, 2017 Mulhern B, Labeit A, Rowen DL, Knowles E, Meadows K, Elliott J & Brazier J Developing preference-based measures for diabetes: DHP-3D and DHP-5D. Diabetic Medicine. In Press. Rowen D, Labeit A, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H, Brazier J. Valuing a preference-based measure on the impact of self-management for diabetes. HEDS discussion paper, 2017 Young T, Yang Y, Brazier J, Tsuchiya A, Coyne K. (2009) The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Quality of Life Research 18:253-265